Application and Effect Evaluation of Medium Chain Fatty Acid Rich Milk Powder in Infants With Cholestatic Liver Disease

Stopped The study could not be conducted as a randomized controlled study due to a change in the protocol, and the study needs to be stopped.

Conditions

• Cholestatic Liver Disease

Interventions

• DIETARY_SUPPLEMENT: Rich medium chain fatty acid milk powder group
• DIETARY_SUPPLEMENT: Regular milk powder group

Sponsor

Children's Hospital of Fudan University